Robert Huebner, Ph.D.
Robert Huebner, Ph.D. was recently appointed to the Missouri Biotechnology Association (MOBIO) Board of Directors.
The MOBIO Board of Directors assists and helps guide MOBIO leadership by promoting the enrichment and growth of bioscience education and industry within Missouri at the state and national levels.
“I hope to use this position to help foster the growth of the bioscience workforce in the Midwest and support collaborations that will grow the industry in the area,” says Dr. Huebner.
Dr. Huebner is an experienced biotechnology program manager with more than 30 years of research and development experience with viral and microbiological pathogens and expertise in the biologics industry, pandemic preparedness, group management, and program management. Throughout his career, he has worked for a variety of organizations, large pharma companies, government agencies, and a contract research organization, holding positions of increasing responsibility.
At LBG, Dr. Huebner supports both commercial and U.S. Government-funded programs as a subject matter expert on biopharmaceutical advanced development, analytical testing, strategic planning, and program management. He also leads the vaccine practice and is part of the team that helps clients win and secure non-dilutive U.S. Government funding.
Prior to joining LBG, Dr. Huebner worked at the Biomedical Research and Development Authority (BARDA) of the Department of Health and Human Services (HHS), where he held several positions, including Deputy Director and Acting Director of the Influenza Division and Chief of Universal Influenza Vaccine Development.
To learn more about MOBIO and its mission, visit http://www.mobio.org.
